Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04441619 · ClinicalTrials.gov registry record · NA

Mechanisms and Modulation of Pain Modulatory Capacity

A NA study of Musculoskeletal Pain, sponsored by University of Florida.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT04441619 is a NA study of Musculoskeletal Pain that is actively recruiting participants, run by University of Florida. The registered enrollment target is 180 participants, above the 151-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (19% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04441619, a NA study of Musculoskeletal Pain, is actively recruiting participants, sponsored by University of Florida.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

This project proposes to understand the sources of pain variability, and demonstrate that pain variability represents fluctuation in natural pain management. The project further proposes to determine if endogenous capacity to modulate pain can be trained to maximize their body's ability to manage pain, much as the way in which athletic performance can be trained.

Conditions Studied

Interventions

  • BEHAVIORAL Delayed onset muscle soreness.

Study Locations (1)

Florida

  • Unversity of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2020-11-30
Est. Completion 2026-04-30
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT04441619

The ClinicalTrials.gov registry entry for NCT04441619 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 151-participant average among 37 other Musculoskeletal Pain trials with a reported enrollment target (19% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Musculoskeletal Pain appearing as the primary indexed condition, and to 1 intervention - of which Delayed onset muscle soreness. is the first listed.

NCT04441619 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT04441619 about?

NCT04441619 is a clinical study titled "Mechanisms and Modulation of Pain Modulatory Capacity". This project proposes to understand the sources of pain variability, and demonstrate that pain variability represents fluctuation in natural pain management. The project further proposes to determine if endogenous capacity to modulate pain can be trained to maximize their body's ability to manage pa...

What is the current status of trial NCT04441619?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2020-11-30. Estimated completion is 2026-04-30.

What conditions does trial NCT04441619 study?

This clinical trial studies the following conditions: Musculoskeletal Pain.

What interventions are being tested in trial NCT04441619?

The interventions under investigation include: Delayed onset muscle soreness. (BEHAVIORAL).

Who is sponsoring clinical trial NCT04441619?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04441619 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Musculoskeletal Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.